Check out Cayuse’s Compliance Management solutions for IRB reviews, COI disclosures, and more to ensure ethical healthcare research with less administrative burden.
Blog
5 Ethical Considerations in Healthcare Research
- Healthcare
Key Takeaways
- Ethical healthcare research involving human subjects requires a careful balance between the perceived benefits of a study and the potential risks to participants
- Study participants must be ethically selected to fairly distribute benefits and burdens and ensure specific populations are not targeted or excluded without a sound scientific reason
- All study participants must be able to provide informed consent; participant consent must be recorded and demonstrated during IRB review
- Research data and personal identifying information (PII) must be securely collected and stored to ensure participant privacy
- All researchers must disclose known or potential financial and personal conflicts of interest before and throughout the study
- Cayuse’s Compliance Management solutions can help healthcare teams manage IRB reviews, COI disclosures, and more with speed and accuracy
Healthcare research is essential to advancing medical knowledge, improving patient care, and ultimately saving lives. However, the pursuit of scientific progress must always be guided by a strong ethical framework to ensure the well-being and rights of participants are respected.
Any healthcare team conducting federally-funded human subjects research must submit the details of their study to an Institutional Review Board (IRB) for review and approval. Proper IRB oversight ensures that the project will proceed with appropriate research ethics taken into consideration. For more information on the IRB process itself, check out our blog on steps, requirements, and timelines.
Among the most vital ethical considerations in healthcare research are equitable participant selection, informed consent and participant autonomy, data security and governance, independent oversight of conflicts of interest, and the delicate balance between benefits and risks.
Equitable and just participant selection
Released in 1978, the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research’s Belmont Report established many of the ethical principles and guidelines that underpin modern ethics standards for human subject research and IRB reviews. The Belmont Report specifically emphasized that the selection of participants should always be equitable and just.
For healthcare research teams, equitable and just participant selection should follow three main principles:
- That no one group should be targeted or excluded from research without sound scientific or ethical rationale
- That benefits and burdens should be fairly distributed
- That subjects are not being systematically selected simply because of their easy availability, their compromised position or their manipulability, but rather for reasons directly related to the problem being studied
There are several reasons why these principles are important to follow while planning a study and recruiting participants.
First, equitable participant selection ensures that the findings of a study will apply equally to a diverse population. If a specific group is arbitrarily targeted or excluded from a study — whether intentionally or not — the study’s results will have much lower generalizability and may be inherently compromised.
Second, researchers must be careful that their studies will not do undue harm to a segment of their participant population. Special considerations must be taken into account for pregnant individuals, for example, to prevent unknown risks to the participants, human fetuses and neonates.
Finally, as we’ll explore further in the next section, research projects cannot proceed with subjects from vulnerable populations who cannot provide informed consent, including those with cognitive impairment, prisoners, and children. If a project must include subjects from vulnerable populations, researchers will need to provide justification for why their participation is necessary and documentation ensuring appropriate safeguards are in place, as outlined by the NIH’s Code of Federal Regulations.
Equitable and just participant selection will be assessed during the IRB review process before a proposed study can proceed. If the IRB finds that appropriate measures have not been taken to ensure equitable participant selection, the research team will need to adjust their selection process to ensure it confirms to the standards outlined above.
Informed consent and participant autonomy
Informed consent is defined as a participant’s voluntary agreement to take part in a study under the following conditions:
- They are provided with clear and comprehensive information about the research’s purpose, procedures, potential risks, and benefits
- They understand all the information they have been given
- They have the opportunity to ask questions and consult others, such as family and friends, before making a decision
Respecting the right to make informed decisions about their involvement in research is a crucial aspect of participant autonomy. It helps to ensure participants are not coerced or deceived into participating against their will and fosters trust between researchers and participants, enhancing compliance and retention.
Obtaining informed consent, however, can be challenging in vulnerable populations, such as those with cognitive impairments or individuals with limited decision-making capacity. Extra precautions must be taken in these cases to protect the rights of participants, whether this involves seeking surrogate consent from legally authorized representatives or employing simplified and easy-to-understand consent forms.
Research administrators can address informed consent concerns and maintain patient autonomy in several ways, including:
- Providing clear guidelines and training sessions to clarify how to obtain informed consent ethically
- Monitoring the informed consent process across research projects and addressing potential ethical issues
- Gathering participant feedback to assess the effectiveness of the informed consent process
When preparing a study protocol for IRB review, researchers must supply documentation confirming that the appropriate steps have been taken to ensure informed consent, including information sheets and written consent forms.
Data security and governance
In this era of digital healthcare research, data security and governance have become paramount ethical considerations. Data governance refers to the framework and policies to guarantee data is collected, stored, and shared in a responsible manner that accords with ethical standards.
Among the most significant data concerns are breaches and privacy violations, where sensitive medical data is exposed without consent or proper safeguards, leading to serious consequences. These can include:
- Medical identity theft, where malicious actors use stolen medical information to fraudulently obtain medical services, prescriptions, or insurance claims
- Stigmatization and discrimination, where individuals’ health conditions or medical history may be subject to prejudice, bias, or exclusion from employment, housing, or social interactions
- Erosion of trust in research organizations, limiting patients from participating in research or sharing critical health information and hindering healthcare advancements
- Legal consequences such as substantial fines, legal actions, and reputational damage
Data sharing and access cannot be completely restricted, as it facilitates scientific collaboration and accelerates discoveries. Research administrators can help strike the right balance, promoting data sharing while protecting individual privacy.
This approach requires establishing clear data protocols within the organization to specify who can access research data, under what conditions, and for what purposes. While data management software can offer a solution, it must be HIPAA compliant. Administrators need to be aware of these requirements and choose accordingly.
During the IRB review process, researchers will likely need to complete a security review form to ensure the privacy and confidentiality of humans participating in research will be protected. This means disclosing how personal identifying information (PII) and research data will be collected, stored and used, often including security certifications for software used to aid the research process. You can read our blog on the topic for more details on essential security certifications to look for in research administration software.
Independent oversight of conflicts of interest
For research teams, conflicts of interest are defined as situations in which personal or financial considerations have the potential to affect or compromise professional bias or objectivity. Because undisclosed conflicts of interest can negatively impact study results and lead to fines, lost funding, and reputational damage, healthcare research teams must establish processes for independently disclosing and managing any potential conflicts.
There are two major conflict of interest categories researchers should keep in mind: financial conflicts and personal conflicts.
Financial conflicts of interest can arise when a researcher has a financial interest in the outcome of their research. This includes situations where the researcher:
- Has equity or stock ownership in companies that would benefit from the results of their research
- Receives income or other compensation from an outside entity
- Maintains property rights and interests related to the research topic.
Conversely, personal conflicts of interest are defined as non-financial conflicts that may impact a researcher or faculty member’s impartiality in regards to a specific project or their research in general. Personal conflicts that require disclosure may vary between healthcare institutions and hospitals, but often cover:
- Relationships with others who may have a financial or personal stake in the results of an individual’s research, such as a spouse who works at a pharmaceutical company
- Non-financial connections to organizations or institutions that may have an interest in the results of an individual’s research, such as unpaid membership on the board of an environmental nonprofit
All known or potential conflicts of interest must be formally disclosed before a proposal is submitted for review and updated during the study if any new conflicts arise. The study’s IRB may review these conflicts, or defer review to a designated COI review committee. For more information on COI disclosure requirements and best practices, check out our blog overview on conflict of interest basics and processes.
Regardless of the reviewing body, researchers should always confirm their institution’s COI disclosure requirements to avoid missing or improperly disclosing conflicts. Today, many healthcare research teams use conflict of interest management software like Cayuse COI to help keep track of conflicts of interest, submit COI disclosures, and amend disclosures as they arise or change over the course of a study’s lifecycle.
Balancing benefits and risks
Another ethical obligation in healthcare research is to minimize harm or discomfort to participants throughout the process. Unnecessary risks must be avoided at all costs, regardless of any hypothetical benefit. Conflicts of interest must also be identified and managed before research is allowed to proceed.
These obligations come with many challenges such as financial ties, professional ambitions, or pressure to publish. Any of these external factors can skew decision-making, undermining the safety of participants and the validity of the results.
While ethical review boards assess the integrity of projects, research administrators can uphold transparency and safety throughout the process by:
- Evaluating the risks associated with research procedures, interventions, or data collection and weighing them against the expected benefits
- Ensuring researchers are prepared to modify their protocols or terminate studies if the risks outweigh the potential benefits
- Closely monitoring any possible conflicts of interest among researchers
- Confirming ethical review boards have access to all relevant information
- Enforcing policies and disclosure requirements to identify potential conflicts of interest
- Fostering a culture of ethical inquiry and accountability within the organization through ongoing ethics training, regular ethical review board evaluations, and clear reporting mechanisms
Facilitate ethical research with Cayuse
In healthcare research, ethical considerations act as a compass, guiding the pursuit of scientific knowledge along moral principles. The importance of informed consent, participant autonomy, data security, and the balancing of benefits and risks cannot be overstated. Upholding all these principles is critical for preserving integrity and patient safety.
Research administrators play a key role in these efforts, and IRB software can help reduce errors and manual effort (read our blog on key capabilities of IRB software for more information on what to look for in an IRB management solution). By utilizing comprehensive digital tools, such as those offered by Cayuse, researchers can maintain transparency and ethical standards throughout the organization while guaranteeing their research is conducted responsibly.
FAQs
Research ethics is a set of moral principles that inform the planning, conduct, and reporting of research to ensure the safety of human and animal subjects.
Ethical considerations in research refer to specific factors taken into account to ensure studies are ethically conducted. These considerations include equitable participant selection, informed consent and participant autonomy, data security and governance, independent oversight of conflicts of interest, and managing the balance between a study’s benefits and risks.
Research ethics ensure that the results of a study are generalizable and not compromised by flaws in the study design that can negatively impact study participants, researchers, and those impacted by a study’s outcome.
An Institutional Review Board (IRB) is a professional committee established to review federally-funded research proposals involving human subjects to ensure they adhere to research ethics.
Informed consent helps to ensure participants are not coerced or deceived into participating against their will and fosters trust between researchers and participants, enhancing compliance and retention.
IRBs review study protocols and related materials, such as informed consent documents and safeguard brochures, to confirm whether the study contains adequate protection measures for its human subjects. The review process always starts before a study begins, and also involves periodic check-ins while the study is in progress. After a review, the IRB will either approve the study, indicating that it can continue, or disapprove it, indicating that revisions are required before the study can proceed.
Vulnerable populations — including children, prisoners, pregnant persons, handicapped, or mentally disabled persons, and economically or educationally disadvantaged persons — must be protected by ensuring they have obtained informed consent to participate in a study, providing a scientifically sound justification for their participation, and by adhering to specific FDA regulations designed to ensure d that their needs and safety are appropriately taken into consideration.
Yes: After a study is approved to move forward, the researchers are still responsible for maintaining IRB compliance. This requires submitting annual continuing review reports, reporting any adverse events or protocol deviations, and submitting protocol amendments for changes to the study design or consent documents. A long study may also require re-approval if its IRB approval expires while the study is still ongoing. Once a study ends, the researchers should also notify the IRB of its completion.
